Willow Creek Wealth Management Inc. Nymox Pharmaceutical Corp Transaction History

Willow Creek Wealth Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Mar 24, 2022	SELL	$0.95 - $2.1 $5,225 - $11,550	-5,500 Reduced 22.7%	18,724 $24,000
Q4 2019 Feb 03, 2020	SELL	$1.73 - $2.42 $17,127 - $23,958	-9,900 Reduced 29.01%	24,224 $53,000
Q1 2019 Apr 25, 2019	BUY	$1.57 - $2.71 $26,002 - $44,883	16,562 Added 94.31%	34,124 $67,000
Q1 2018 Apr 26, 2018	BUY	$3.09 - $4.43 $54,266 - $77,799	17,562 New	17,562 $74,000

150K

Ticker NYMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,265,000
Market Cap $42.9M
Description
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperpl...

Get notified when there are updates to the investment portfolio of Willow Creek Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Willow Creek Wealth Management Inc. with notifications on news.